| Pharmaceutical Information |
| Drug Name |
Nepafenac |
| Drug ID |
BADD_D01555 |
| Description |
Nepafenac is a non-steroidal anti-inflammatory prodrug (NSAID) usually sold as a prescription eye drop. It is used to treat pain and inflammation associated with cataract surgery. |
| Indications and Usage |
For the treatment of pain and inflammation associated with cataract surgery. |
| Marketing Status |
approved; investigational |
| ATC Code |
S01BC10 |
| DrugBank ID |
DB06802
|
| KEGG ID |
D05143
|
| MeSH ID |
C414203
|
| PubChem ID |
151075
|
| TTD Drug ID |
D02IHW
|
| NDC Product Code |
73309-311; 53296-0099; 64181-0019; 42571-353; 58567-104; 86036-006; 0078-0743; 69988-0005; 0078-0778 |
| UNII |
0J9L7J6V8C
|
| Synonyms |
nepafenac | 2-amino-3-benzoylbenzeneacetamide | Nevanac |
|
| Chemical Information |
| Molecular Formula |
C15H14N2O2 |
| CAS Registry Number |
78281-72-8 |
| SMILES |
C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
